
Tailoring Treatment Intensity in HNSCC: The Expanding Role of Cancer Immunotherapy
Webinar InformationWebinar Description Immunotherapy has become integrated into therapy for many solid tumors. As this new modality has evolved through recurrent/metastatic and recently into the locally advanced setting, new insights and dangers have been encountered, providing insights into complex interactions of conventional modalities with immunotherapeutic modulation of the tumor microenvironment and clinical benefit for patients. The roles of treatment intensification and de-intensification using immunotherapy will be discussed. Learning Objectives
|
Webinar RegistrationYou must have an account and be logged in to register for and to access the course. Please contact us with any questions at [email protected] or (919) 445–1000.
|
![]() | Robert L. Ferris, MD, PhD Executive Director |
DisclosuresActivity Directors ACCME ANCC |
Accreditation Statements1.00 AMA PRA Category 1 Credit™ 1.00 NCPD/CNE |
NoticeIn most cases, regulations prohibit the repeated use of the same educational activity (Live Webinar or Self-Paced, Online Course but not both) as it relates to satisfying CE requirements to maintain licensure. Attendees are also required to view a minimum of 53 minutes of the live webinar video to receive CE credit. Please contact your individual accreditation agencies for more details. Altering or submitting modified certificates constitutes fraud that can result in punitive action by the accrediting agency. |
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 NCPD/CNE
- 1.00 Participation
You must have an account and be logged in to register for and to access the course.
FREE Continuing Education Credit Requirements
Attendees have 7 days from the webinar air date to complete the online evaluation, select type of continuing education credit, and download a certificate. See our detailed instructions for more information on attending live webinars and receiving credit. Please contact us with any questions at [email protected] or (919) 445–1000. |